Role of Monocyte-Acquired Hemozoin in Suppression of Macrophage Migration Inhibitory Factor in Children with Severe Malarial Anemia

ABSTRACT Severe malarial anemia (SMA), caused by Plasmodium falciparum infections, is one of the leading causes of childhood mortality in sub-Saharan Africa. Although the molecular determinants of SMA are largely undefined, dysregulation in host-derived inflammatory mediators influences disease severity. Macrophage migration inhibitory factor (MIF) is an important regulator of innate inflammatory responses that has recently been shown to suppress erythropoiesis and promote pathogenesis of SMA in murine models. To examine the role of MIF in the development of childhood SMA, peripheral blood MIF production was examined in Kenyan children (aged <3 years, n = 357) with P. falciparum malarial anemia. All children in the study were free from bacteremia and human immunodeficiency virus type 1. Since deposition of malarial pigment (hemozoin [Hz]) contributes to suppression of erythropoiesis, the relationship between MIF concentrations and monocytic acquisition of Hz was also examined in vivo and in vitro. Circulating MIF concentrations declined with increasing severity of anemia and significantly correlated with peripheral blood leukocyte MIF transcripts. However, MIF concentrations in peripheral blood were not significantly associated with reticulocyte production. Multivariate regression analyses, controlling for age, gender, and parasitemia, further revealed that elevated levels of pigment-containing monocytes (PCM) was associated with SMA and decreased MIF production. In addition, PCM levels were a better predictor of hemoglobin and MIF concentrations than parasite density. Additional experiments in malaria-naive individuals demonstrated that hemozoin caused both increased and decreased MIF production in cultured peripheral blood mononuclear cells (PBMC) in a donor-specific manner, independent of apoptosis. However, PBMC MIF production in children with acute malaria progressively declined with increasing anemia severity. Results presented here demonstrate that acquisition of hemozoin by monocytes is associated with suppression of peripheral blood MIF production and enhanced severity of anemia in childhood malaria.

[1]  J. Vulule,et al.  Parasitemia, anemia, and malarial anemia in infants and young children in a rural holoendemic Plasmodium falciparum transmission area. , 2006, The American journal of tropical medicine and hygiene.

[2]  S. Kaufmann,et al.  Macrophage migration inhibitory factor (MIF) plays a pivotal role in immunity against Salmonella typhimurium , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[3]  R. Bucala,et al.  An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[4]  B. Lowe,et al.  Bacteraemia complicating severe malaria in children. , 1999, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[5]  H. Ginsburg,et al.  Impairment of Macrophage Functions after Ingestion of Plasmodium s Erythrocytes or Isolated Malarial Pigment , 2003 .

[6]  C. Dye,et al.  World Malaria Report, 2008. , 2008 .

[7]  L. Tetley,et al.  Protective effect on Leishmania major infection of migration inhibitory factor, TNF-alpha, and IFN-gamma administered orally via attenuated Salmonella typhimurium. , 1998, Journal of Immunology.

[8]  G. Yap,et al.  Production of Soluble Inhibitor of Erythropoiesis during Plasmodium chabaudi AS Infection in Resistant and Susceptible Mice a , 1991, Annals of the New York Academy of Sciences.

[9]  M. Molyneux,et al.  Clinical presentation of non-typhoidal Salmonella bacteraemia in Malawian children. , 2000, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[10]  J. Nishihira,et al.  Quantitation of macrophage migration inhibitory factor (MIF) using the one-step sandwich enzyme immunosorbent assay: elevated serum MIF concentrations in patients with autoimmune diseases and identification of MIF in erythrocytes. , 2000, International journal of molecular medicine.

[11]  V. Nussenblatt,et al.  Anemia and Interleukin-10, Tumor Necrosis Factor Alpha, and Erythropoietin Levels among Children with Acute, Uncomplicated Plasmodium falciparum Malaria , 2001, Clinical Diagnostic Laboratory Immunology.

[12]  V. Adabayeri,et al.  Low plasma concentrations of interleukin 10 in severe malarial anaemia compared with cerebral and uncomplicated malaria , 1998, The Lancet.

[13]  B. Nahlen,et al.  In vivo acquisition of hemozoin by placental blood mononuclear cells suppresses PGE2, TNF-alpha, and IL-10. , 2003, Biochemical and biophysical research communications.

[14]  S. Abdalla Hematopoiesis in human malaria. , 1990, Blood cells.

[15]  J. Hittner,et al.  A macrophage migration inhibitory factor promoter polymorphism is associated with high-density parasitemia in children with malaria , 2006, Genes and Immunity.

[16]  J. Breman,et al.  The intolerable burden of malaria: a new look at the numbers. , 2001, The American journal of tropical medicine and hygiene.

[17]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[18]  J. Vulule,et al.  Increased severe anemia in HIV-1-exposed and HIV-1-positive infants and children during acute malaria , 2006, AIDS.

[19]  A. Satoskar,et al.  Migration-Inhibitory Factor Gene-Deficient Mice Are Susceptible to Cutaneous Leishmania major Infection , 2001, Infection and Immunity.

[20]  D. Weatherall,et al.  The Anaemia of P. falciparum Malaria , 1980, British journal of haematology.

[21]  K. Tracey,et al.  Malaria-specific metabolite hemozoin mediates the release of several potent endogenous pyrogens (TNF, MIP-1 alpha, and MIP-1 beta) in vitro, and altered thermoregulation in vivo. , 1995, Journal of inflammation.

[22]  Weltgesundheitsorganisation World malaria report , 2005 .

[23]  J. Oppenheim,et al.  Biochemical characterization of Plasmodium falciparum hemozoin. , 1990, The American journal of tropical medicine and hygiene.

[24]  R. Gbadegesin,et al.  Intraleucocytic malaria pigment and clinical severity of malaria in children. , 1998, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[25]  R. Snow,et al.  Host-parasite interaction and morbidity in malaria endemic areas. , 1997, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[26]  D. Weatherall,et al.  The anaemia of Plasmodium falciparum malaria. , 1982, British medical bulletin.

[27]  P. Silverman,et al.  Inhibition of erythropoiesis by a soluble factor in murine malaria. , 1989, Experimental hematology.

[28]  K. Tracey,et al.  MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia , 1993, Nature.

[29]  J. Hittner,et al.  Reduced Peripheral PGE2 Biosynthesis in Plasmodium falciparum Malaria Occurs through Hemozoin-Induced Suppression of Blood Mononuclear Cell Cyclooxygenase-2 Gene Expression via an Interleukin-10-Independent Mechanism , 2004, Molecular medicine.

[30]  B. Nahlen,et al.  Immunity to placental malaria. IV. Placental malaria is associated with up-regulation of macrophage migration inhibitory factor in intervillous blood. , 2002, The Journal of infectious diseases.

[31]  B. Nahlen,et al.  A low interleukin-10 tumor necrosis factor-alpha ratio is associated with malaria anemia in children residing in a holoendemic malaria region in western Kenya. , 1999, The Journal of infectious diseases.

[32]  H. Webster,et al.  Plasmodium falciparum pigment induces monocytes to release high levels of tumor necrosis factor-alpha and interleukin-1 beta. , 1994, The American journal of tropical medicine and hygiene.

[33]  Chris Newbold,et al.  Relation between severe malaria morbidity in children and level of Plasmodium falciparum transmission in Africa , 1997, The Lancet.

[34]  P. Arese,et al.  Phagocytosis of the Malarial Pigment, Hemozoin, Impairs Expression of Major Histocompatibility Complex Class II Antigen, CD54, and CD11c in Human Monocytes , 1998, Infection and Immunity.

[35]  I. Clark,et al.  The pathophysiology of falciparum malaria. , 2003, Pharmacology & therapeutics.

[36]  J. Hittner,et al.  Differential Regulation of β-Chemokines in Children with Plasmodium falciparum Malaria , 2005, Infection and Immunity.

[37]  P. Silverman,et al.  Murine malaria decreases hemopoietic stem cells. , 1987, Blood.

[38]  J. Bernhagen,et al.  The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor , 1994, The Journal of experimental medicine.

[39]  M. McDevitt,et al.  A critical role for the host mediator macrophage migration inhibitory factor in the pathogenesis of malarial anemia , 2006, The Journal of experimental medicine.

[40]  Clark,et al.  Possible importance of macrophage-derived mediators in acute malaria , 1981, Infection and immunity.

[41]  J. David Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction. , 1966, Proceedings of the National Academy of Sciences of the United States of America.

[42]  N. White,et al.  Clearance kinetics of parasites and pigment-containing leukocytes in severe malaria. , 1996, Blood.

[43]  B. Mordmüller,et al.  Malaria pigment in leucocytes. , 1995, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[44]  O. Rodrigues,et al.  Reversible suppression of bone marrow response to erythropoietin in Plasmodium falciparum malaria , 1997, British journal of haematology.

[45]  R. Steketee,et al.  Effect of blood transfusion on survival among children in a Kenyan hospital , 1992, The Lancet.

[46]  A. Satoskar,et al.  Macrophage Migration Inhibitory Factor Contributes to Host Defense against Acute Trypanosoma cruzi Infection , 2006, Infection and Immunity.

[47]  A. Satoskar,et al.  Targeted Disruption of Migration Inhibitory Factor Gene Reveals Its Critical Role in Sepsis , 1999, The Journal of experimental medicine.

[48]  M. Molyneux,et al.  Tissue distribution of migration inhibitory factor and inducible nitric oxide synthase in falciparum malaria and sepsis in African children , 2003, Malaria Journal.

[49]  J. Hittner,et al.  Elevated Nitric Oxide Production in Children with Malarial Anemia: Hemozoin-Induced Nitric Oxide Synthase Type 2 Transcripts and Nitric Oxide in Blood Mononuclear Cells , 2004, Infection and Immunity.

[50]  V. Poshyachinda,et al.  Ferrokinetic studies and erythropoiesis in malaria. , 1969, Archives of internal medicine.

[51]  P. Kremsner,et al.  Increased erythropoietin production in children with severe malarial anemia. , 1995, The American journal of tropical medicine and hygiene.

[52]  S N Wickramasinghe,et al.  Blood and bone marrow changes in malaria. , 2000, Bailliere's best practice & research. Clinical haematology.

[53]  P. Kremsner,et al.  Reduced interleukin-12 and transforming growth factor-beta1 in severe childhood malaria: relationship of cytokine balance with disease severity. , 2000, The Journal of infectious diseases.

[54]  R. Bucala,et al.  Macrophage Migration Inhibitory Factor Release by Macrophages after Ingestion of Plasmodium chabaudi-Infected Erythrocytes: Possible Role in the Pathogenesis of Malarial Anemia , 2000, Infection and Immunity.

[55]  T. Calandra,et al.  Macrophage migration inhibitory factor: a regulator of innate immunity , 2003, Nature Reviews Immunology.

[56]  D. Ray,et al.  Glucocorticoids suppress macrophage migration inhibitory factor (MIF) expression in a cell-type-specific manner. , 2004, Journal of molecular endocrinology.

[57]  J. Weinberg,et al.  Monocyte chemotactic peptide receptor. Functional characteristics and ligand-induced regulation. , 1981, The Journal of clinical investigation.

[58]  S. Looareesuwan,et al.  Reduced levels of transforming growth factor-beta1, interleukin-12 and increased migration inhibitory factor are associated with severe malaria. , 2004, Acta tropica.

[59]  P. V. Perkins,et al.  Plasmodium falciparum incidence relative to entomologic inoculation rates at a site proposed for testing malaria vaccines in western Kenya. , 1994, The American journal of tropical medicine and hygiene.

[60]  P. Arese,et al.  Malarial pigment (haemozoin): a very active 'inert' substance. , 1997, Annals of tropical medicine and parasitology.

[61]  J. Hittner,et al.  Disorders of Erythropoiesis • Brief Report Suppression of RANTES in children with Plasmodium falciparum malaria Tom , 2022 .

[62]  J. Bernhagen,et al.  Migration inhibitory factor induces killing of Leishmania major by macrophages: dependence on reactive nitrogen intermediates and endogenous TNF-alpha. , 1998, Journal of immunology.

[63]  A. Monto,et al.  Effect of Plasmodium falciparum parasitemia density on hemoglobin concentrations among full-term, normal birth weight children in western Kenya, IV. The Asembo Bay Cohort Project. , 2000, The American journal of tropical medicine and hygiene.

[64]  D. Ferguson,et al.  Intraleucocytic malaria pigment and prognosis in severe malaria. , 1995, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[65]  R. Bucala,et al.  Protection from septic shock by neutralization of macrophage migration inhibitory factor , 2000, Nature Medicine.

[66]  B. Lell,et al.  Low Interleukin-12 Activity in Severe Plasmodium falciparum Malaria , 2000, Infection and Immunity.

[67]  L. Tetley,et al.  Protective Effect on Leishmania major Infection of Migration Inhibitory Factor, TNF-α, and IFN-γ Administered Orally via Attenuated Salmonella typhimurium , 1998, The Journal of Immunology.

[68]  B. Nahlen,et al.  Immunohistological Characterization of Macrophage Migration Inhibitory Factor Expression in Plasmodium falciparum-Infected Placentas , 2005, Infection and Immunity.

[69]  N. Petrovsky,et al.  Response of serum macrophage migration inhibitory factor levels to stimulation or suppression of the hypothalamo-pituitary-adrenal axis in normal subjects and patients with Cushing's disease. , 2002, The Journal of clinical endocrinology and metabolism.

[70]  K. Diane Schooley, and L. , 1994 .

[71]  J. Hittner,et al.  Decreased circulating macrophage migration inhibitory factor (MIF) protein and blood mononuclear cell MIF transcripts in children with Plasmodium falciparum malaria. , 2006, Clinical immunology.

[72]  M. McDevitt,et al.  The anemia of malaria infection: role of inflammatory cytokines. , 2004, Current hematology reports.

[73]  A. Dicko,et al.  Association of intraleukocytic Plasmodium falciparum malaria pigment with disease severity, clinical manifestations, and prognosis in severe malaria. , 2003, The American journal of tropical medicine and hygiene.